Kintara Therapeutics to Present at the MedInvest Oncology Investor Conference on December 9, 2021 December 7, 2021 • 8:00 AM EST
Kintara Announces First International Site Activation in GCAR Phase 2/3 Clinical Trial for Glioblastoma November 30, 2021 • 8:00 AM EST
Kintara Presents Updates on Two Phase 2 Clinical Studies at the 2021 Society for Neuro-oncology Annual Meeting November 18, 2021 • 8:00 AM EST
Kintara Therapeutics Announces Fiscal 2022 First Quarter Financial Results and Provides Corporate Update November 15, 2021 • 8:15 AM EST
Kintara Therapeutics to Present at the Q4 Investor Summit Virtual Conference on November 17, 2021 November 11, 2021 • 8:30 AM EST
Kintara Therapeutics Announces Fiscal Year 2021 Financial Results and Provides Corporate Update September 29, 2021 • 8:00 AM EDT
Kintara Announces Closing of $15.0 million Offering Priced at a Premium to Market September 28, 2021 • 1:33 PM EDT
Kintara Announces $15.0 million Offering of Common Stock and Warrants Priced at a Premium to Market September 24, 2021 • 8:00 AM EDT